COVID-19 in patients with cancer: managing a pandemic within a pandemic

The coronavirus disease 2019 (COVID-19) pandemic has disrupted health care worldwide. Patients with cancer seem to be particularly susceptible to morbidities and mortality from this novel disease. No COVID-19-specific therapy currently seems to offer a survival benefit to this unique patient populat...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nature reviews. Clinical oncology 2021-01, Vol.18 (1), p.1-2
Hauptverfasser:	Horn, Leora, Garassino, Marina
Format:	Artikel
Sprache:	eng
Schlagworte:	692/4028 706/648 Cancer Cancer patients Care and treatment Comment Comorbidity Control Coronaviruses COVID-19 COVID-19 - epidemiology COVID-19 - prevention & control COVID-19 - virology Demographic aspects Epidemics Humans Italy Medical Oncology - methods Medicine Medicine & Public Health Neoplasms - chemically induced Neoplasms - epidemiology Neoplasms - therapy Oncology Pandemics SARS-CoV-2 - isolation & purification SARS-CoV-2 - physiology United States
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The coronavirus disease 2019 (COVID-19) pandemic has disrupted health care worldwide. Patients with cancer seem to be particularly susceptible to morbidities and mortality from this novel disease. No COVID-19-specific therapy currently seems to offer a survival benefit to this unique patient population. Furthermore, the global effects on routine cancer care will likely be felt for decades to come.
ISSN:	1759-4774 1759-4782
DOI:	10.1038/s41571-020-00441-5